Search results
AstraZeneca withdraws Covid-19 vaccine, citing low demand | CNN Business
CNN.com· 7 days agoThe vaccine — called Vaxzevria and developed in partnership with the University of Oxford — has been...
Stock market today: Wall Street rises as it cruises toward the close of another winning week
The Columbian· 4 days agoU.S. stocks are heading toward the close of another winning week with some more modest gains on...
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
WKRN Nashville· 5 days agoAnnounces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19
Dogness Announces Entry into US$5.0 Million Private Placement
telegraphherald.com· 5 days agoDogness (International) Corporation ("Dogness" or the "Company") (NASDAQ: DOGZ), a developer and manufacturer of a comprehensive line of Dogness-branded, OEM and private label pet products, ...
Fed Rate Cuts Remain Elusive. Why Markets Can’t Count on Inflation Data for Insight and 5 Other...
Barrons.com· 2 days agoFed officials are also struggling to get a clear idea of what’s happening. There will be plenty of ...
LiveOne (Nasdaq: LVO) Hits New Milestones
NewMediaWire via Yahoo Finance· 13 hours ago- Surpasses 3.75M Total Members a +26% YoY Increase; Adds Record 62K New Paid Members in April- Tesla Membership Tops 1.76M a +31% YoY Increase- Expects...
Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home...
Digital Journal· 6 days ago...available market for the company's products will not be as large as expected, the company's products will not be able to penetrate one or more targeted markets, revenues will not be sufficient to meet the company's cash needs, fund further development, as well as uncertainties relative to the ...
Novavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoNovavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript May 12, 2024 Novavax, Inc. isn’t one of...
NanoViricides to Participate in the 2024 EF Hutton Annual Global Conference On May 15 in New York...
The Joplin Globe· 5 days agoSHELTON, CT / ACCESSWIRE / May 10, 2024 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, today announces ...
MPR News Podcasts
MPR News· 4 days agoCheck out MPR News podcasts, the latest from Minnesota Today to in-depth conversations on news and culture with Angela Davis and stories from around Minnesota with Cathy Wurzer.